Keynote Speakers
Radiochemistry and Total Body PET
Dr. Robert Mach
University of Pennsylvania, United States of America
Robert H. Mach is the Britton Chance Professor of Radiology and Director of the PET Radiochemistry Program at the University of Pennsylvania. Dr. Mach is a past President of the Radiopharmaceutical Sciences Council of the Society of Nuclear Medicine and Molecular Imaging and a former member of the Board of Directors of the Society of Radiopharmaceutical Sciences. He has over 275 peer-reviewed publications and book chapters and holds 27 patents on the development of PET-based radiopharmaceuticals. Research in his lab is focused on the development of radiotracers for studying the molecular basis of disease using the imaging technique, positron emission tomography or PET. Current research projects include the development of radiotracers for imaging: 1) dopamine D3 receptors in addiction; 2) alpha synuclein in Parkinson’s disease and other synucleinopathies; 3) PARP-1 in cancer and CNS disorders; and 4) the role of oxidative stress in inflammation and neuroinflammation. His laboratory is also studying cancer cell biology, and identified the role of the ternary complex between the sigma-2 receptor/TMEM97, LDL receptor, and progesterone receptor membrane component 1 (PGRMC1) in providing the high levels of cholesterol needed to support cell proliferation.
The Future is Ours: FAP in Image-Guided Therapy
Dr. Frederik Giesel
University of Heidelberg, Germany
Dr. Frederik Giesel studied medicine at the Universities of Mainz and Heidelberg in Germany. After graduating from medical school, Dr. Giesel went to the National Institutes of Health (NIH) in Bethesda, Maryland (USA) during his residency. He also holds an executive MBA-program at the Frankfurt School of Finance in Germany. Since 2015, Dr. Giesel has served as a professor of radiology and vice chair for nuclear medicine at the University Hospital Heidelberg, and was recently a visiting professor at Stanford University in the United States and Yonsei University in South Korea. He has published over 200 original articles and over 600 scientific abstracts on international scientific conferences. Dr. Giesel leads clinical trials with new PET tracers, including PSMA and FAP ligands. Since Mai 2021 he is elected as the new chair of nuclear medicine at the University Hospital Duesseldorf, Germany..
Compact cyclotrons and Lab-on-a-Chip - a pathway to dose-on-demand PET tracers?
Prof. Nicole Pamme
University of Hull, England
Nicole Pamme obtained a Diploma in Chemistry from the University of Marburg (Germany). For her Ph.D. studies, she went to Imperial College London (UK) where she joined the group of Prof. Andreas Manz. It was here that she first started working with microfluidic devices, more specifically, on single particle analysis inside microfluidic channels. She then moved to Tsukuba (Japan) as an independent research fellow in the International Centre for Young Scientists (ICYS) based at the Japanese National Institute for Materials Science. This was followed by an appointment as a Lecturer in Analytical Chemistry at the University of Hull in the UK with promotions to Senior Lecturer, Reader, and finally Professor. Her research revolves around the study of microfluidic lab-on-a-chip devices for environmental analysis on-site, for clinical diagnostics at the point-of-care as well as synthesis and quality control of radiopharmaceuticals. She has authored >120 peer-reviewed publications in this area. She is a Fellow of the Royal Society of Chemistry (FRSC) and a Fellow of the Higher Education Academy (FHEA). Prof. Pamme is an Associate Editor of Analyst (RSC) and serves on the editorial advisory boards of Analytical Chemistry (ACS), Lab on a Chip (RSC), and Analytica Chimica Acta (Elsevier). She currently also serves as President of the Chemical and Biological Microsystems Society (CBMS).